Sandbox ID Upper Respiratory Tract: Difference between revisions

Jump to navigation Jump to search
Gerald Chi- (talk | contribs)
Gerald Chi- (talk | contribs)
mNo edit summary
Line 12: Line 12:
::* Other oral anaerobes
::* Other oral anaerobes
:* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Metronidazole]] 0.5 g IV q6h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h
:* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Metronidazole]] 0.5 g IV q6h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} Imipenem 500 mg IV q6h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Gatifloxacin]] 400 mg IV q24h
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Gatifloxacin]] 400 mg IV q24h


===Laryngitis===
===Laryngitis===
Line 27: Line 27:
::* Other oral anaerobes
::* Other oral anaerobes
:* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Metronidazole]] 0.5 g IV q6h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h
:* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Metronidazole]] 0.5 g IV q6h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} Imipenem 500 mg IV q6h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Gatifloxacin]] 400 mg IV q24h
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Gatifloxacin]] 400 mg IV q24h


===Ludwig's angina===
===Ludwig's angina===
Line 38: Line 38:
::* Other oral anaerobes
::* Other oral anaerobes
:* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Tobramycin]] 2 mg/kg IV q8h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h {{or}} [[Doxycycline]] 200 mg IV q12h {{or}} [[Cefoxitin]] 2 g IV q6h {{or}} [[Cefotetan]] 2 g IV q12h  
:* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Tobramycin]] 2 mg/kg IV q8h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h {{or}} [[Doxycycline]] 200 mg IV q12h {{or}} [[Cefoxitin]] 2 g IV q6h {{or}} [[Cefotetan]] 2 g IV q12h  
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} Imipenem 500 mg IV q6h {{or}} [[Meropenem]] 1 g IV q8h {{or}} [[Gatifloxacin]] 200 mg IV q24h
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Meropenem]] 1 g IV q8h {{or}} [[Gatifloxacin]] 200 mg IV q24h


===Parapharyngeal space infection===
===Parapharyngeal space infection===
Line 50: Line 50:
::* Other oral anaerobes
::* Other oral anaerobes
:* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Metronidazole]] 0.5 g IV q6h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h
:* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Metronidazole]] 0.5 g IV q6h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} Imipenem 500 mg IV q6h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Gatifloxacin]] 400 mg IV q24h
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Gatifloxacin]] 400 mg IV q24h


===Pharyngitis, diphtheria===
===Pharyngitis, diphtheria===
Line 79: Line 79:
::* Other oral anaerobes
::* Other oral anaerobes
:* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Tobramycin]] 2 mg/kg IV q8h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h {{or}} [[Doxycycline]] 200 mg IV q12h {{or}} [[Cefoxitin]] 2 g IV q6h {{or}} [[Cefotetan]] 2 g IV q12h  
:* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Tobramycin]] 2 mg/kg IV q8h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h {{or}} [[Doxycycline]] 200 mg IV q12h {{or}} [[Cefoxitin]] 2 g IV q6h {{or}} [[Cefotetan]] 2 g IV q12h  
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} Imipenem 500 mg IV q6h {{or}} [[Meropenem]] 1 g IV q8h {{or}} [[Gatifloxacin]] 200 mg IV q24h
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Meropenem]] 1 g IV q8h {{or}} [[Gatifloxacin]] 200 mg IV q24h


===Tonsillitis===
===Tonsillitis===

Revision as of 07:53, 11 June 2015

Epiglottitis

Jugular vein phlebitis

  • Septic jugular thrombophlebitis (Lemierre's syndrome)[1]
  • Causative pathogens
  • Fusobacterium
  • Viridans and other streptococci
  • Staphylococcus
  • Peptostreptococcus
  • Bacteroides
  • Other oral anaerobes

Laryngitis

Lemierre's syndrome

  • Septic jugular thrombophlebitis (Lemierre's syndrome)[2]
  • Causative pathogens
  • Fusobacterium
  • Viridans and other streptococci
  • Staphylococcus
  • Peptostreptococcus
  • Bacteroides
  • Other oral anaerobes

Ludwig's angina

  • Ludwig's angina[3]
  • Causative pathogens
  • Viridans and other streptococci
  • Peptostreptococcus
  • Bacteroides
  • Other oral anaerobes

Parapharyngeal space infection

  • Parapharyngeal space infection[4]
  • Causative pathogens
  • Viridans and other streptococci
  • Staphylococcus
  • Peptostreptococcus
  • Bacteroides
  • Other oral anaerobes

Pharyngitis, diphtheria

Pharyngitis, streptococcal

Sinusitis, Acute

Sinusitis, Chronic

Sinusitis, Post-intubation

Sinusitis, Treatment failure

Stomatitis

Stomatitis, aphthous

Stomatitis, herpetic

Submandibular space infection

  • Submandibular space infections including Ludwig angina[5]
  • Causative pathogens
  • Viridans and other streptococci
  • Peptostreptococcus
  • Bacteroides
  • Other oral anaerobes

Tonsillitis

Ulcerative gingivitis

Vincent's angina

  1. Hall, Jesse (2015). Principles of critical care. New York: McGraw-Hill Education. ISBN 978-0071738811.
  2. Hall, Jesse (2015). Principles of critical care. New York: McGraw-Hill Education. ISBN 978-0071738811.
  3. Hall, Jesse (2015). Principles of critical care. New York: McGraw-Hill Education. ISBN 978-0071738811.
  4. Hall, Jesse (2015). Principles of critical care. New York: McGraw-Hill Education. ISBN 978-0071738811.
  5. Hall, Jesse (2015). Principles of critical care. New York: McGraw-Hill Education. ISBN 978-0071738811.